Product name | Sucrose (for injection) |
Chemical name | |
Molecular formula | |
CAS No. | 57-50-1 |
CDE Record registration Number | F20200000093(A) |
FDA DMF Number | 035209 |
Grade | injection Grade |
Quality standards | comply with Chp, USP, EP or other pharmacopoeia requirements |
Sufficient supply, cost-effective | |
Description | |
Applications | Liposome active drug loading novel excipient (Irinotecan liposome) |
Molecular weight | |
Product Code | O09001 |
Available Package Sizes | 10kg |
High quality: It complies with the ChP, USP, EP and other mainstream pharmacopoeias; Key indicators such as color value, conductivity, bacterial endotoxins and microbial limits are much stricter than the pharmacopoeia requirements; Supporting the product registration abroad.
The product has been certified by a third-party authority, SGS. Stable cooperation with major pharmaceutical companies in China has been achieved;
Adequate production capacity: annual supply of 300 tons +, with the ability of expansion to 1,000 tons +/year;
Ready supply: Sufficient stock, rapid supply;
Controllable cost: significantly reduces procurement costs and improves product competitive advantage.
Sucrose is effective in reducing membrane fusion, protecting liposome particles from rupture and drug leakage during freeze-drying process, and regulating osmotic pressure. Compared with mannitol, glucose, etc., it has a higher glass transition temperature and better viscosity protection. The general dosage is 5%–10%. In addition, sucrose also plays the role of vehicle in lyophilized preparations. Studies have shown that adding sucrose has an impact on the shape, porosity and collapse of the lyophilized preparations.
If you have any questions, please don't hesitate to contact us. We're always here to help with Pharmaceutical Excipients for your business. We can provide products ranging from grams to tons. AVT is able to produce and even register the product in US FDA according to your special needs.